Sensei Biotherapeutics, Inc. (NASDAQ:FTH) Stock Has Consensus Target Price of $56.25 According to Analysts
Sensei Biotherapeutics, Inc. (NASDAQ:FTH – Get Free Report) has been given a consensus rating of “Moderate Buy” by the fifteen ratings firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, eleven have given a buy rating and two […]
25 Sep 04:29 · The Cerbat Gem